HUM:NYE-Humana Inc. (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 288.12

Change

+0.36 (+0.13)%

Market Cap

USD 30.56B

Volume

1.69M

Analyst Target

USD 448.08
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Humana Inc is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+9.44 (+1.53%)

USD 566.72B
ELV Elevance Health Inc

+2.77 (+0.66%)

USD 95.26B
CNC Centene Corp

+0.60 (+1.00%)

USD 30.37B
MOH Molina Healthcare Inc

-1.06 (-0.32%)

USD 18.86B
OSCR Oscar Health Inc

+0.26 (+1.92%)

USD 4.12B
NEUE NeueHealth Inc

-0.04 (-0.79%)

USD 0.05B
CI Cigna Corp

+23.29 (+7.28%)

N/A
CVS CVS Health Corp

+0.27 (+0.49%)

N/A

ETFs Containing HUM

TUSB:CA TD Select U.S. Short Term.. 2.16 % 0.28 %

+0.02 (+0.65%)

CAD 9.94M
TUSB-U:CA TD Select U.S. Short Term.. 2.16 % 0.00 %

N/A

CAD 8.25M
SRHQ Elevation Series Trust - .. 1.84 % 0.00 %

+0.37 (+0.65%)

N/A
CVMC Morgan Stanley ETF Trust .. 0.50 % 0.00 %

+0.40 (+0.65%)

N/A
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.97 (+0.65%)

N/A
MUS:CA 0.00 % 0.58 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

+0.74 (+0.65%)

N/A
VETS 0.00 % 0.60 %

N/A

N/A
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -37.07% 75% C 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -37.07% 75% C 15% F
Trailing 12 Months  
Capital Gain -41.57% 63% D 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.57% 63% D 11% F
Trailing 5 Years  
Capital Gain -9.28% 83% B 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.28% 83% B 42% F
Average Annual (5 Year Horizon)  
Capital Gain 1.43% 13% F 39% F
Dividend Return 2.10% 13% F 33% F
Total Return 0.67% 40% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 19.88% 88% B+ 55% F
Risk Adjusted Return 10.57% 13% F 29% F
Market Capitalization 30.56B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 27.50 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector